IceCure Medical Ltd. Cash and Restricted Cash
IceCure Medical Ltd. (ICCM) had Cash and Restricted Cash of $8.90 million as of 2025-12-31, per its 20-F filed 2026-03-17.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-17
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.90M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.38M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.56M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.65M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $8.90M 20-F · filed 2026-03-17 |
| 2025-06-30 | $5.38M 6-K · filed 2025-08-13 |
| 2024-12-31 | $7.56M 20-F · filed 2026-03-17 |
| 2024-06-30 | $9.65M 6-K · filed 2025-08-13 |
| 2023-12-31 | $10.53M 20-F · filed 2026-03-17 |
| 2023-06-30 | $3.03M 6-K · filed 2024-08-20 |
| 2022-12-31 | $23.66M 20-F · filed 2026-03-17 |
| 2022-06-30 | $13.47M 6-K · filed 2023-08-14 |
| 2021-12-31 | $25.62M 20-F · filed 2025-03-27 |
| 2021-06-30 | $18.61M 6-K · filed 2022-09-22 |
| 2020-12-31 | $3.50M 20-F · filed 2024-04-03 |
| 2019-12-31 | $5.79M 20-F · filed 2023-03-29 |
| 2018-12-31 | $4.21M 20-F/A · filed 2022-08-22 |